Vollständiger Abstract
Worum geht es in dieser Arbeit?
Anaplastic pleomorphic xanthoastrocytoma (APXA) is a rare pediatric high-grade glioma (pHGG). We report a 10-year-old boy with a left temporal APXA harboring a BRAF V600E mutation, who presented with generalized tonic–clonic seizures 3–4 times weekly, treated with combined BRAF and MEK inhibition. This case illustrates the utility of [ 18 F]FDOPA PET in monitoring targeted therapy, providing metabolic information that preceded and complemented conventional imaging.
Bibliografischer Nachweis
Publikationsdaten
- Autor:innen
- Jacopo Passoni, Andrea Rossi, Claudia Milanaccio, Arnoldo Piccardo, Francesco Fiz
- Quelle
- Clinical Nuclear Medicine
- Publikation
- 2026-01-01
- Band / Ausgabe
- Nicht angegeben
- Seiten
- Nicht angegeben
- ISSN / ISBN
- 0363-9762, 1536-0229
- Zitationen
- 0 laut Crossref
- Referenzen
- 0 hinterlegt
Zitieren
Zitierfähiger Nachweis
Jacopo Passoni, Andrea Rossi, Claudia Milanaccio, Arnoldo Piccardo, Francesco Fiz (2026). Posttherapy [18F]FDOPA PET Findings in an Anaplastic Pleomorphic Xanthoastrocytoma With a BRAF V600E Mutation. Clinical Nuclear Medicine. https://doi.org/10.1097/rlu.0000000000006698